Building on the Broad’s strengths of scaling scientific efforts to accelerate progress, this event, jointly hosted by L2C and the Eric and Wendy Schmidt Center, facilitated new connections between biologists and AI/ML experts to showcase efforts in scaling mechanisms-focused research in the pursuit of therapeutic discovery for patients with rare diseases and beyond.